Compass Therapeutics (CMPX) Interest Coverage Ratio (QoQ) (2018 - 2026)
Compass Therapeutics (CMPX) Interest Coverage Ratio (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.65% |
| Dec 31, 2025 | -13,119.81% |
| Sep 30, 2025 | 54.37% |
| Jun 30, 2025 | 64.38% |
| Sep 30, 2024 | 95.48% |
| Jun 30, 2024 | -638.70% |
| Mar 31, 2024 | 86.77% |
| Dec 31, 2023 | -32.94% |
| Sep 30, 2023 | -2,055.64% |
| Jun 30, 2023 | 83.41% |
| Mar 31, 2023 | 24.65% |
| Dec 31, 2022 | -2.30% |
| Sep 30, 2022 | -292.04% |
| Jun 30, 2022 | 55.26% |
| Mar 31, 2022 | 92.82% |
| Dec 31, 2021 | -7,769.87% |
| Sep 30, 2020 | -29.29% |
| Jun 30, 2020 | -8.27% |
| Mar 31, 2020 | -169.38% |
| Dec 31, 2019 | 75.37% |